Indirect comparison from network meta-analyses suggests these rough equivalencies for weight loss outcomes: Liraglutide 3 mg daily ~ tirzepatide 2.5 to 5 mg weekly Liraglutide 3 mg daily ~ semaglutide 0.5 mg weekly Liraglutide 1.8 mg daily ~ semaglutide 0.25 mg weekly or dulaglutide 0.75 mg weekly These arent FDA-endorsed conversions
Updated systematic reviews further support the idea that GLP-1 RA administration does not inherently increase DR risk through specific class effects of incretin hormones but rather reflects a common phenomenon of rapid hypoglycemia correction from severe hyperglycemia (143, 147149)
Clear deposit methods, sensible withdrawal timeframes, and flexible limits add to peace of mind
This article incorporates text from this source, which is in the public domain.
A Population Reflecting Real-World Complexity Approximately 61% of patients with psoriasis in the United States also have obesity or overweight with at least one weight-related comorbidity
Possibly some mild nausea, though sublingual formulations tend to produce less GI disturbance at initiation than injections because the daily dose is smaller and the peak concentration is lower